Vernon R G, Faulkner A, Finley E, Watt P W, Zammit V A
Hannah Research Institute, Ayr, UK.
J Dairy Res. 1995 May;62(2):237-48. doi: 10.1017/s0022029900030946.
The effects of prolonged (22 weeks) treatment of lactating goats with bovine somatotropin on the metabolism of adipose tissue and liver has been investigated. Somatotropin treatment resulted in smaller adipocytes, decreased rate of fatty acid synthesis and decreased total acetyl-CoA carboxylase activity of adipocytes, but with no change in the proportion of this enzyme in the active state. The rate of acylglycerol glycerol synthesis from glucose of adipocytes tended to decrease as did total glucose utilization by the tissue. Glucose conversion to lactate was unchanged by somatotropin treatment but glucose conversion to other products was decreased. Maximum response of adipose tissue to insulin was unchanged but the sensitivity to insulin decreased on somatotropin treatment. Treatment with somatotropin had no effect on basal lipolysis and decreased maximum response to the beta-agonist isoproterenol, but this probably reflects the rate of isoproterenol-stimulated lipolysis varying with cell volume in adipocytes. No apparent change in response either to alpha 2-adrenergic agonists or to adenosine was apparent. The number of beta-adrenergic receptors was unchanged in adipocyte membranes but the number of alpha 2-adrenergic receptors increased. The rate of hepatic gluconeogenesis in vitro, the activity of key gluconeogenic enzymes and the modulation of the rate of gluconeogenesis by butyrate were unchanged except for the effect of this latter agent on gluconeogenesis from propionate. Hepatic ketogenic activity, as indicated by the activity of carnitine palmitoyl-CoA-transferase-1 and the concentrations of carnitine and acyl carnitines, was unchanged by treatment. Thus at the end of a prolonged period of treatment with somatotropin in lactating goats, lipid synthesis in adipose tissue is still decreased but no effects on liver lipid and carbohydrate metabolism were apparent.
研究了用牛生长激素对泌乳山羊进行长期(22周)治疗对脂肪组织和肝脏代谢的影响。生长激素治疗导致脂肪细胞变小,脂肪酸合成速率降低,脂肪细胞中总乙酰辅酶A羧化酶活性降低,但该酶处于活性状态的比例没有变化。脂肪细胞从葡萄糖合成酰基甘油的速率趋于降低,组织对葡萄糖的总利用率也降低。生长激素治疗对葡萄糖转化为乳酸没有影响,但葡萄糖转化为其他产物减少。脂肪组织对胰岛素的最大反应没有变化,但生长激素治疗后对胰岛素的敏感性降低。生长激素治疗对基础脂肪分解没有影响,对β-激动剂异丙肾上腺素的最大反应降低,但这可能反映了异丙肾上腺素刺激的脂肪分解速率随脂肪细胞体积而变化。对α2-肾上腺素能激动剂或腺苷的反应没有明显变化。脂肪细胞膜中β-肾上腺素能受体的数量没有变化,但α2-肾上腺素能受体的数量增加。除丁酸盐对丙酸糖异生的影响外,体外肝脏糖异生速率、关键糖异生酶的活性以及丁酸盐对糖异生速率的调节均未改变。治疗对肝脏生酮活性没有影响,以肉碱棕榈酰辅酶A转移酶-1的活性以及肉碱和酰基肉碱的浓度表示。因此,在对泌乳山羊进行长期生长激素治疗结束时,脂肪组织中的脂质合成仍然降低,但对肝脏脂质和碳水化合物代谢没有明显影响。